Merck Serono - Transforming lives through medical science

The product portfolio of this division includes leading prescription medicines such as the cancer drug Erbitux® and the multiple sclerosis treatment Rebif®. In addition, Merck Serono offers therapies to treat infertility, growth disorders, cardiovascular and metabolic diseases. Reseach and development activities focus on the core therapeutic areas of oncology, neurodegenerative diseases and rheumatology.

Merck Serono's enduring commitment and focus in specialist indications enable the division to deliver targeted medicines and innovative drug delivery systems to patients all over the world. In 2010, Merck Serono generated 61% of its sales with its five top-selling biopharmaceuticals. In medical biotechnology, Merck Serono is the leader in Europe. In order to further expand this position, we are currently expanding Europe’s most modern biotechnology manufacturing facility, located in Switzerland.